New Japan Price Cut Push Has Industry Worried
Industry groups in Japan have reacted swiftly and strongly to planned government discussions on changes to drug pricing policies, warning that the adoption of annual price cuts would "undo all the policy achievements" of the past few years.
You may also be interested in...
Japan's government has released a new "road map" for the development of the generic drug sector, setting an ambitious new five-year target for such products to reflect faster than expected sales expansion following recent policy changes.
Japanese major links with new partners in European consortium to progress first-in-class molecule for multiple hematological malignancies.
A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.